Hu Pitie Salpetriere Aphp

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• ALS (motor neurone disease)1 trial
• Obesity1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Rhythm Pharmaceuticals, Inc.1 trial
• University Hospital, Lille1 trial

Closed trials

• Completed

  EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

  NCT05093634· Phase 3· Rhythm Pharmaceuticals, Inc.· Source

• Completed

  Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis

  NCT03293069· Phase 2/3· University Hospital, Lille· Source